The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family

E-ISSN： 1873-4286|18|27|4165-4186

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.27, 2012-09, pp. : 4165-4186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Non-Nucleoside Reverse Transcriptase Inhibitors for Anti-HIV Therapy

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 2, 2008-04 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the DABOs Family as Potent HIV-1 non-Nucleoside Reverse Transcriptase Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2376-2385

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances of Diaryl Ether Family as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 15, 2013-03 ,pp. : 2829-2838

Bentham Science Publishers

Access to resources Recommend Favorite